As of 2025-04-21, the Relative Valuation of Fortress Biotech Inc (FBIO) is (52.18) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.53 USD, the upside of Fortress Biotech Inc based on Relative Valuation is -3510.5%.
The range of the Relative Valuation is (42.83) - (71.06) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 27.5x - 45.6x | 36.5x |
| Forward P/E multiples | 23.5x - 46.4x | 30.5x |
| Fair Price | (42.83) - (71.06) | (52.18) |
| Upside | -2899.7% - -4744.4% | -3510.5% |
| Date | P/E |
| 2025-04-17 | -0.98 |
| 2025-04-16 | -0.96 |
| 2025-04-15 | -0.98 |
| 2025-04-14 | -1.01 |
| 2025-04-11 | -0.94 |
| 2025-04-10 | -0.91 |
| 2025-04-09 | -0.93 |
| 2025-04-08 | -0.92 |
| 2025-04-07 | -0.94 |
| 2025-04-04 | -0.98 |
| 2025-04-03 | -0.98 |
| 2025-04-02 | -1.03 |
| 2025-04-01 | -0.99 |
| 2025-03-31 | -1.00 |
| 2025-03-28 | -1.03 |
| 2025-03-27 | -1.11 |
| 2025-03-26 | -1.08 |
| 2025-03-25 | -1.12 |
| 2025-03-24 | -1.10 |
| 2025-03-21 | -1.10 |
| 2025-03-20 | -1.09 |
| 2025-03-19 | -1.10 |
| 2025-03-18 | -1.10 |
| 2025-03-17 | -1.12 |
| 2025-03-14 | -1.07 |
| 2025-03-13 | -1.04 |
| 2025-03-12 | -1.11 |
| 2025-03-11 | -1.11 |
| 2025-03-10 | -1.12 |
| 2025-03-07 | -0.99 |
| 2025-03-06 | -0.98 |
| 2025-03-05 | -1.00 |
| 2025-03-04 | -0.98 |
| 2025-03-03 | -0.98 |
| 2025-02-28 | -1.01 |
| 2025-02-27 | -1.01 |
| 2025-02-26 | -1.03 |
| 2025-02-25 | -1.03 |
| 2025-02-24 | -1.01 |
| 2025-02-21 | -1.04 |
| 2025-02-20 | -1.04 |
| 2025-02-19 | -1.06 |
| 2025-02-18 | -1.08 |
| 2025-02-14 | -1.10 |
| 2025-02-13 | -1.13 |
| 2025-02-12 | -1.11 |
| 2025-02-11 | -1.10 |
| 2025-02-10 | -1.12 |
| 2025-02-07 | -1.15 |
| 2025-02-06 | -1.17 |